Ads
related to: paid clinical trials
Search results
Summit Therapeutics stock rallies as institutional buyer loads up on shares | Invezz
Invezz· 5 days agoSummit Therapeutics Inc (NASDAQ: SMMT) says it raised $200 million via an offer it accepted from an...
Karyopharm therapeutics director sells over $785,000 in company stock By Investing.com
Investing.com· 4 hours agoDeepika Pakianathan, director at Karyopharm Therapeutics Inc. (NASDAQ:KPTI), a pharmaceutical...
Monterey County Jail sued for 6th time for wrongful death since 2021
KSBW Salinas· 2 hours agoAIR-BLOWER BACKPACK.... SO FAR NO ARREST HAVE BEEN MADE...### ANOTHER LAWSUIT HAS BEEN FILED ..OVER...
Eli Lilly adds ALS drug prospect with QurAlis deal
BioPharma Dive via Yahoo Finance· 5 days agoThe alliance hands Lilly an RNA-based therapy in preclinical testing for ALS and frontotemporal dementia, and includes a research collaboration to...
Georgia couple asks for dismissal of child abuse case, says child's injuries were misdiagnosed
First Coast News· 7 days agoGough, who represents Corey Sullivan, has filed a motion for a speedy trial, a motion for him to be...
Should You Buy the 3 Highest-Yielding Dividend Stocks in the Nasdaq-100?
Motley Fool via Yahoo Finance· 3 days agoFor instance, two of Gilead's candidate drugs -- sacituzumab govitecan and magrolimab -- recently...
What’s wrong with your brain? It could come down to what you need more of each night
Miami Herald via Yahoo News· 3 days agoExperts are encouraging people to pay attention to their health and speak with their doctors if they...
New Research Links High Testosterone Levels With This Common Heart Condition
Health.com· 3 days agoThe research builds off previous studies finding a relationship between testosterone levels and...
These Dentist-Approved Mouthwashes Will Zap Bad Breath and Help Prevent Cavities
Prevention via Yahoo News· 4 days agoMost toothpastes contain anionic compounds, and mouthrinses contain cationic compounds. When...
Citi sets Sensei Biotherapeutics stock to buy with $4 target By Investing.com
Investing.com· 4 days agoOn Monday, Citi resumed coverage of Sensei Biotherapeutics (NASDAQ:SNSE) with a Buy rating, and a...